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Abstract 
Objective: To investigate the preference for urinary catheters that can reduce the frequency of urinary 
tract infections (UTIs), among Swedish patients practicing clean intermittent catheterization (CIC), and 
analyze if the preference is affected by the frequency of UTIs and gender. 
 
Methods: The preference for a clinically more effective catheter was expressed as a monetary value 
by investigating the patients’ willingness-to-pay (WTP) to switch catheters. The results were stratified 
on annual frequency of UTIs and gender.  
 
An electronic questionnaire was sent by e-mail to 144 Swedish users of intermittent catheters. The 
participants were asked to assume a situation in which they use their current catheter but had the 
choice to switch to a similar catheter, which hypothetically would reduce the frequency of UTIs 
including possible complications. Either every fourth or every second UTI could be avoided.  
 
The participants were asked to report their frequency of UTIs and their willingness-to-pay for the new 
catheter was collected by letting them choose to spend either one of eleven explicit monthly amounts 
from 0–1000 SEK or any other amount in an open answer. Only individuals stating that they were 
‘certain’ or ‘very certain’ regarding their answers were included in the analyses. Statistical analyses 
were performed with non-parametric testing methods. 
 
Results: 96 individuals returned the questionnaire, of which 42 males and 28 females were certain or 
very certain regarding their answers. The proportion of respondents with ≤1 UTI/year and ≥2 
UTI/year was 74% and 26%, respectively. The respondents were willing to spend on average 120 SEK 
each month to avoid every fourth UTI and 174 SEK each month to avoid every second UTI. The results 
to avoid every fourth and every second UTI, respectively, showed no difference between men and 
women but having ≥2 UTI/year reached statistical significance. 
 
Conclusion The CIC users in this study, who practice intermittent catheterization on a daily basis, 
expressed a preference for catheters that could help to decrease the frequency of urinary tract 
infections as expressed by a willingness to pay for more effective catheters. The result was dependent 
on the annual frequency of UTIs but not gender. 
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Introduction 
Clean intermittent catheterization1 (CIC) was introduced in the early 1970s and has since then proved 
to be an efficient method in the management of neuropathic bladders to solve problems with 
incontinence and dysuria. There are many indications for CIC, for instance in spinal cord injured (SCI) 
patients as a mode of voiding at the initial phase in an intensive care unit after an injury, during the 
period of the bladder retraining and as a long-term solution to empty the bladder.2  
 
Complications of intermittent catheterization 
Even though intermittent catheterization is an efficient method for SCI patients, there are 
complications associated with the procedure. A retrospective study of 159 SCI patients investigated 
the overall rate of complications of CIC.3 Ninety-two of the patients used CIC only temporarily for the 
mean length of 3.5 months. Sixty-seven of the patients continued to use CIC in the medium and long 
term for a mean period of 2 years and 8 months. The study showed that 60% of the patients had an 
asymptomatic cytobacteriological infection. Twenty-eight percent (28%) developed a symptomatic 
lower urinary tract infection (UTI).4 Ten percent (10%) of the men had epididymitis. In addition, 
strictures occurred in 5.3% of the male population with a mean delay of 2 years and 6 months. Bladder 
stones were seen in 2% of the patients. 
 
A literature review investigating the complications of intermittent catheterization, found that 
infections in the urinary tract is the most common complication, but the prevalence of UTIs varies. To 
prevent UTIs, a non-infecting technique is needed.5 
 
In a study where 302 CIC treated patients were followed for a mean time of 13 months, approximately 
3 out of 4 patients experienced urinary tract infections. 58.3% of the patients had minor symptoms, 
14.3% had more comprehensive or frequent symptoms and 2.6% major symptoms.6 
 
                                                          
1 Clean intermittent catheterization involves the passing of a hollow tube through the urethra several times per day to 
empty the bladder 
2 Perrouin-Verbe B, Labat JJ, Richard I, et al. ‘Clean intermittent catheterisation from the acute period in spinal cord injury 
patients. Long term evaluation of urethral and genital tolerance. Paraplegia vol. 33, 1994, pp. 619-624 
3 Perroiun-Verbe, Paraplegia, pp. 619-624 
4 UTI is defined as positive urine culture with pyuria and one or more systemic symptoms as fever, loin pain, dysuria, 
urgency, hematuria 
5 Wyndaele JJ, Complications of intermittent catheterization: their prevention and treatment. Spinal Cord, vol. 40, 2002, pp. 
536-541. 
6 Bakke A, Vollset SE, Høisæter PÅ, et al. Physical complications in patients treated with clean intermittent catheterization. 
Scand J Urol Nephrol, vol. 27, 1993, pp. 55-61. 
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In 77 CIC patients completing a 5 year study, 81% were treated for UTI at least once. Twenty-two 
percent (22%) had 2-3 UTIs per year and 12% four or more UTIs per year.7 
 
A recent cost utility study evaluated the cost effectiveness of different catheter types.8 The health 
economic model incorporated clinical data into a probabilistic Markov Model consisting of key health 
states between which the patients moved with certain transition probabilities. The development of 
UTI and difficulties to treat the infection was central to the model. The annual transition probability 
for UTI was 67.7%. It was 8.3% for UTI resistant to first line antibiotic, 7% for multidrug resistant UTI 
and lastly 3.6% for UTI associated bacteremia. Not only do the UTIs and associated complications 
impose a substantial cost to any health care system, but they also affect the patients’ quality of life. 
 
Impact of UTIs on quality of life 
In a national survey performed in Canada, 912 SCI patients responded to a 36 item questionnaire to 
collect information on clinical demographic data, techniques and use of IC, occurrence of UTIs and 
consequences of having UTIs. The mean frequency of self-reported UTIs in the past 12 months was 2.6. 
Females had more UTIs than men, 3.2 and 2.4 respectively. Twenty-three percent (23%) felt ill for an 
average of 4 days or longer with a UTI, 15% had missed work or school and 34% had refrained from 
social activities because of UTIs.  Seventy-one percent (71%) of the respondents said that UTIs 
negatively impacted their quality of life. There was a positive relationship between the number of UTIs 
and the impact of UTIs on quality of life. 9 
 
The cost utility analysis by Bermingham et al. (2013) assumed a relationship between individuals’ 
quality of life and the health outcomes achieved as a consequence of each intervention. The authors 
also meant that where preferences have implications for the costs and outcomes, it is important to 
include these in the models. Although important, it is unfortunately difficult to find data on patient 
preferences to include in health economic models.10 
 
                                                          
7 Biering-Sorensen F, Nielans HM, Dorflinger T, et al. Urological situation five years after spinal cord injury. Scand J Urol 
Nephrol, vol. 33, 1999, pp. 157-161. 
8 Bermingham S, Hodgkinson S, Wright S, et al. Intermittent self-catheterization with hydrophilic, gel reservoir, and non-
coated catheters: a systematic review and cost effectiveness analysis. British Medical Journal, 2013, pp. 1-16. 
9 Woodbury MG, Hayes KC, Askes HK. Intermittent catheterization practices following spinal cord injury: a national survey. 
The Canadian Journal of Urology, vol. 15(3), June 2008, pp. 4065-4071 
10 Bermingham, BMJ, 2013, p. 6. 
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Catheters for intermittent catheterization 
In a Cochrane review from 2007, long-term bladder management by intermittent catheterization in 
adults and children was discussed. 11  Different intermittent catheterization methods and catheter 
types were compared regarding their ability to reduce the incidence of urinary tract infections (UTIs), 
hematuria, other infections and which method the patients’ prefer. Fourteen studies met the inclusion 
criteria. With the available data it was not possible to support a favorable catheter type in a mixed 
group of patients in need to empty their bladder for various reasons. The authors mean patient 
satisfaction, acceptability and preferences are important secondary outcome variables which need to 
be included in clinical trials evaluating urinary catheters. These parameters are particularly important 
in assessing the cost-effectiveness of single-use products such as urinary catheters. 
 
A recent review article which compared two types of catheters, coated catheters and non-coated, 
found a difference regarding reported UTIs and hematuria events. There were significantly less 
reported UTIs in the group receiving coated catheters, 50% versus 72%. There were also less hematuria 
cases among the patients with coated catheters, 46% versus 55%.12  
 
Infections have an impact on patients’ quality of life and they are costly to the health care system.  A 
reduction in the frequency of catheter-associated UTIs will benefit the patients, the health care 
organizations and payers of health care.  
 
Purpose and research questions 
This health economic analysis focused on the patient perspective of UTIs. The patients in need for 
intermittent catheters evaluated a hypothetical situation where they could experience less UTIs and 
associated complications by switching to a similar urinary catheter as the one they already used.  
 
The preference for a clinically more effective catheter was expressed as a monetary value by 
investigating the patients’ willingness-to-pay (WTP) to switch catheters. The results were stratified on 
annual frequency of UTIs and gender.  
                                                          
11 Moore KN, Fader M, Getliffe K. Long-term bladder management by intermittent catheterization in adults and children. 
Cochrane Database of Systematic Reviews 2007, Issue 4. 
12 Li L, Wenqin Y, Hong R, et al. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: 
systematic review and meta-analysis of randomized controlled trials. Archives of Physical Medicine and Rehabilitation, vol. 
94, 2013, pp. 782-787. 
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This study investigated the following questions: 
 What is the willingness-to-pay in Sweden - from a patient perspective - for a urinary catheter 
which reduces the annual frequency of urinary tract infection by 25% and 50%, respectively?  
 Is the patients’ willingness-to-pay for a more effective catheter dependent on the annual 
frequency of UTIs or gender? 
 What is the additional value of a more effective catheter from a healthcare perspective? 
 
Hypotheses 
The null hypotheses tested in the study were: 
(1) Probability that willingness-to-pay is 0 SEK at p-level 0.05.  
(2) Probability of no difference in willingness-to-pay between men and women.  
(3) Probability of no difference in willingness-to-pay between UTI frequency ≤1/year and UTI 
frequency ≥2/year. 
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Methods 
Health economics is a discipline that analyzes the economic aspects of health and health care and 
usually focuses on the costs and the consequences of health care interventions, using methods and 
theories from economics and medicine. A health economic evaluation is a tool to facilitate decision-
making in the healthcare system and to improve the welfare.13 
 
All economic evaluations have a common structure which involves explicit measurements of inputs 
(‘costs’) and outcomes (‘benefits’).  At least two comparators are needed to be able to perform an 
economic evaluation and to say something about the cost-effectiveness of the investigated medical 
intervention. There are four types of analyses to consider when the cost-effectiveness of an 
intervention should be assessed (table 1).14 
 
 
ANALYSIS COST MEASURE OUTCOMES MEASURE 
Cost-minimization SEK No 
Cost-effectiveness SEK 
Life-years gained, symptom-
free days, clinical endpoint 
Cost-utility SEK 
Quality-adjusted life-years 
(QALYs) 
Cost-benefit SEK SEK 
 
Table 1.  Health economic analyses for assessing the cost-effectiveness of an intervention. 
 
All analyses share the same input, which are all costs associated with the interventions. These costs 
can be either direct as for instance the cost of the medical interventions, hospital care, physician 
visits and rehabilitation or indirect such as sick leave, early retirement and family support.15 
                                                          
13 Ferraz-Nunes J, Karlberg I and Bergström G. Ekonomi, sjukvård och hälsa. In: Hälsoekonomi – begrepp och tillämpningar. 
79-82. Malmö: Studentlitteratur. 2007 
14 Drummond MF, O’Brien B., Stoddart GL. and Torrance GW. Basic types of economic evaluation. In Methods for the 
Economic Evaluations of Health.  6-26. Oxford: Oxford University Press. 1997 
15 In addition to the four health economic analyses, it is also possible to investigate how the intervention affects the 
health care budget in a Budget Impact Analysis. In such an analysis the cost for the health care payer is in focus.  
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When two interventions with the same efficacy are compared, a cost-minimization analysis can be 
chosen. In most situations there is a difference in outcomes between the comparative interventions 
and a different type of analysis is needed. Often a cost-effectiveness or cost-utility analysis is 
performed, which are methods of economic evaluation where the value of the resources spent on an 
intervention is compared with the quantity of health gained as a result.  
 
The value of a medical intervention must be identified and quantified to be able to perform a health 
economic analysis. A challenge for MedTech companies and their products is to define the 
meaningful value of the device. The value can for instance be described from the patients’ 
perspective or the healthcare perspective. It can depend on the learning curve and if the medical 
device is integrated in a complex procedure or not. In the case of intermittent urinary catheters, 
which are used 4-6 times per day, not only the clinical outcome or quality of life gains are important. 
Also, the convenience factors experienced by the patients constitute a value which needs to be 
investigated.  
 
Assessing patient preferences16 
The Dental and Pharmaceutical Benefits Board (TLV) in Sweden is a central government agency which 
regularly evaluate pharmaceuticals and dental products with regard to their cost effectiveness and 
determines if the products should be subsidized by the state. Recently the government mandated TLV 
to also investigate how MedTech products could be evaluated from an economical perspective. 
Guidelines on how to perform a health economic analysis – for instance for single use products such 
as urinary catheters – were released 2011 within the so called ‘Medical Device Project’. 
 
For new products with a proposed added benefit in comparison to one or more comparators, a health 
economic assessment showing an acceptable cost per benefit should be provided. Thereby, TLV can 
assess the new product’s cost effectiveness. TLV suggests Medtech companies to perform either a cost 
benefit or cost utility analysis. 
 
A cost-benefit analysis is useful when the relative risks and benefits of a new product are known to the 
patient and have a direct and episodic effect. It is appropriate when an added value, as experienced 
by the patient, is not easily measured with a quality of life instrument to support a cost-utility analysis. 
                                                          
16 Tandvårds- och läkemedelsförmånsverket, Handbok till Tandvårds- och läkemedelsförmånsverkets föreskrifter (TLVFS 
2011:3) om ansökan om pris och subvention för förbrukningsartiklar, Sept. 2011, viewed on 28 Aug. 2013, 
http://www.tlv.se/Upload/Foretag/Handbok-TLVFS2011-3-subvention-forbrukningsartiklar-sept-2011.pdf 
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In a cost-benefit analysis, the benefit is measured as the average willingness-to-pay (WTP) and the cost 
effectiveness assessed as the net monetary benefit.  
 
The value of specific products with various product features can be assessed by letting the patients 
reveal their willingness-to-pay (WTP) for the compared alternatives. If the difference in WTP between 
a new product and a comparator exceeds the difference in cost between the products, the new 
product can be considered cost effective. 
 
Patients are the primary source when asking questions regarding the willingness-to-pay for a product. 
It is important to ask questions, which measure the same behaviour as when the patients purchase 
ordinary consumer goods.  A WTP-study can either use interviews or questionnaires. Personal 
interviews normally generate more reliable results. Web questionnaires are generally not suitable 
unless a random sample from a relevant population can be assured. 
 
Study design 
The method chosen to answer the research questions was a quantitative research approach where 
data was collected through a questionnaire and the answers analyzed with a non-parametric statistical 
method. The questionnaire was sent electronically to users of intermittent catheterization. The 
patients had previously given their permission to be registered in a global database called TellUs, which 
is a database of intermittent catheter users held by Wellspect Healthcare in Mölndal. 
 
Wellspect Healthcare is a company developing catheters for intermittent use. The company is using 
the TellUs database to interact with users of intermittent urinary catheters, primarily users of the 
LoFric® catheter assortment. At the time of the study, the database included approximately 1000 users 
from the following countries: Denmark, Germany, Italy, Norway, Sweden, United Kingdom and USA.  
 
The patient preferences for catheters, which can reduce the frequency of UTIs, were investigated by 
sending the questionnaire to 144 TellUS participants from Sweden, who could be reached with an 
email.  
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Patient selection  
This study focused on the Swedish TellUs users - both men and women – in need of intermittent urinary 
catheters for any medical reason.  
 
An analysis of the whole cohort of TellUs patients from the markets in Europe and in the USA, showed 
that the recruitment of users to the database for market surveys, have generated a mixed group of 
individuals, both with respect to gender, age and reasons for using urinary catheters. The 
characteristics of the Swedish patients included in the study were comparable to the other countries 
(see attachment 2). The selected TellUS cohort was therefore likely a representative sample of 
intermittent catheter users and suitable to participate in the study.  
 
The patients in the Swedish TellUs database are primarily users of a specific catheter brand belonging 
to the category hydrophilic catheters. On the other hand, well above 90% of the Swedish market 
consists of hydrophilic catheters. 
 
Ethical consideration 
The users’ participation in the electronic survey was voluntary.  A request to participate in the survey 
was sent to them via e-mail, where they also found the login details to get access to the questions. The 
collected individual answers were anonymized and transferred to an excel file for statistical analysis, 
which occurred at a group level where each respondent received a serial number. All survey data in 
the database was deleted after the completion of the analysis to make it impossible to search for 
individual answers as the survey contained questions related to health. 
 
Description of survey 
The participants were asked to assume a situation in which they use their current catheter but had 
the choice to switch to a similar catheter, which hypothetically would reduce the frequency of UTIs 
including possible complications (see attachment 1). Either every fourth or every second UTI could be 
avoided.  
 
The participants’ willingness-to-pay for the new catheter was collected by letting them choose to 
spend either one of eleven explicit monthly amounts from 0 SEK–1000 SEK or any other amount in an 
open answer.  The participants also reported their UTI frequency.  
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The validity and reliability must be taken into consideration, when choosing an instrument or 
designing a survey. Validity means to what extent a measurement tool, for instance a survey, 
measures what it is expected to measure. The reliability of an investigatory experiment or statistical 
test means that the same or comparable results can be generated in repeated experiments.17 
 
The survey was designed to answer the research questions in the purpose. To avoid conflicting answers 
and answers difficult to interpret, free text options were avoided and defined lists of answers chosen 
when possible. In addition, few questions were included and only those relevant for the purpose of 
the study. The explicit amounts to measure the willingness-to-pay were derived from the cost of 
treating a UTI in the healthcare setting. 
 
Before initiating the study, the complicating fact to ask for out-of-pocket payment to receive treatment 
in a tax-financed healthcare system, was considered. The situation was therefore explained to the 
respondents, that they had to answer to an imaginary situation and that the explicit amounts reflected 
a value they experienced from having fewer UTIs and associated complications. Nevertheless, there 
might be a resistance among some respondents to pay anything at all for treatments that normally are 
for free. In such a case, the WTP would be an underestimation of the true value brought to the patients 
from having fewer UTIs and complications. To limit the amount of protest votes and to avoid 
uncertainties regarding the assessment of WTP, only respondents who were certain of their answer 
were included in the statistical analyses.18 
 
Statistical testing19 
Both descriptive and analytical statistics were performed. The descriptive statistics was used to 
present the mean UTI frequency and the distribution of the WTP testing and proceeded the 
significance testing. All statistical tests which were used for significance testing required that the 
individuals in each group had been selected randomly and were independent from each other, which 
was the case with the survey used in this study. The survey was sent to all accessible individuals in 
the Swedish TellUS database and the participation was voluntary and no selection occurred. 
Thereafter the patients were split in groups defined by gender and self-reported annual frequency of 
UTIs. 
                                                          
17 Gunnarson R. Validitet och reliabilitet. [Dept. of Prim Health Care Göteborg University - Research methodology web 
site]. May 8, 2010. Available at: http://infovoice.se/fou. Accessed November 20, 2014. 
18 Tandvårds- och läkemedelsförmånsverket, sid 16. (2013) 
19 Gunnarson R. Att välja statistisk metod. [Dept. of Prim Health Care Göteborg University - Research methodology 
web site]. May 8, 2010. Available at: http://infovoice.se/fou. Accessed November 25, 2014. 
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Non parametric tests 
The investigated WTP parameter was quantitative. The study population and each group were 
relatively small and the WTP-values not normally distributed, as expected in a tax financed system 
where patients unwilling to spend anything at all could be proportionally large. As a consequence, 
non-parametric tests were chosen to investigate the hypotheses. 
 
Wilcoxon rank sum test20 
The Wilcoxon one sample signed rank sum test is a non-parametric test. It can be can be used for 
significance testing where one group is compared to a fixed value, for instance 0, and when the 
quantitative parameter has a skewed distribution. In this study, the Wilcoxon signed rank sum test was 
useful as the willingness-to-pay answers were tested against the null hypothesis that there is no 
willingness-to-pay for a better urinary catheter. 
 
Mann-Whitney test21 
The Mann-Whitney test is used to compare the mean between two non-matched groups of 
individuals. It is the non-parametric equivalent to the parametric test called Student t-test.  To 
perform a Mann-Whitney test, the distributions of values in the comparative groups are equal but 
skewed. There is no need for the values to be normally distributed. The Mann-Whitney test was used 
to test if there were any differences in WTP between men and women and if it was dependent on 
the UTI frequency, respectively. 
 
Kruskal-Wallis one-way analysis of variance22 
The Kruskal-Wallis method is the same as the Mann-Whitney test, but with the essential difference 
that more than two non-matched groups of individuals can be compared. It is the non-parametric 
equivalent to the parametric test one-way ANOVA. Also for Kruskal-Wallis, the distributions of values 
in each group are equal but skewed. The Kruskal-Wallis one-way analysis of variance was used to test 
if there was a significant difference between the subgroups of men and women with no more than 
                                                          
20 Gunnarson R. Översikt över signifikansanalys. [Dept. of Prim Health Care Göteborg University - Research 
methodology web site]. Jan 2, 2003. Available at: http://infovoice.se/fou. Accessed November 26, 2014 
21 Gunnarson R. Rangsummetest (Mann-Whitney’s Test). [Dept. of Prim Health Care Göteborg University - Research 
methodology web site]. Jan 1, 2002. Available at: http://infovoice.se/fou. Accessed November 24, 2014  
22 Gunnarson R. Kruskal-Wallis one way analysis of variance. [Dept. of Prim Health Care Göteborg University - 
Research methodology web site]. Jan 1, 2002. Available at: http://infovoice.se/fou. Accessed November 24, 2014  
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one UTI per year or two or more UTIs. Mann-Whitney tests were thereafter performed to see which 
subgroup contributed the most to the results.  
15 
 
Results 
 
Descriptive statistics 
The electronic survey was sent by e-mail to 144 Swedish users of intermittent catheters. 96 users 
responded to the survey which gave a response rate of 67% (fig. 1). 26 of them were excluded due to 
uncertain and very uncertain answers. The willingness-to-pay analyses were performed on the 42 
males and 28 females who were certain or very certain of their answers (fig. 2). 
 
Figure 1. Total number of survey respondents 
 
 
 
Figure 2. Number of certain and very certain answers 
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Seventy-four percent (74%, n=52) of the respondents included in the analyses had one or no urinary 
tract infection per year. Thirty-nine percent (39%) had no UTIs.  Twenty-six (26%, n=18) of them had 
two or more UTIs (fig. 3). The two groups were compared to investigate whether the willingness-to-
pay differed depending on the frequency of UTIs.  
 
Figure 3. The number of respondents included in the analyses with UTI≤1 and UTI≥2, respectively 
 
 
Eighty-one percent (81%, n=34) of the male respondents had one or no urinary tract infection. 
Nineteen percent (19%) had more than one urinary tract infection. The corresponding frequencies 
for the female respondents were 64% (n=18) and 36% (n=10), respectively (fig. 4). 
 
Figure 4. The number of men and women included in the analyses with UTI≤1 and UTI≥2, respectively 
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The mean annual number of UTIs among the respondents in the study was 1.23. Women had more 
UTIs per year than men, 1.71 versus 0.90 (fig. 5). 
 
 
 
Figure 5.  The mean number of UTIs among the respondents in the analysis 
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Willingness to pay results for the whole sample 
The willingness-to-pay to avoid every fourth UTI, for all the respondents, was 120 SEK and to avoid 
half of the UTIs 174 SEK (fig. 6).  
 
 
 
Figure 6. Willingness-to pay (WTP) to avoid UTIs (SEK) 
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A substantial proportion of the respondents did not want to spend any money out-of-pocket for the 
prevention of UTIs and associated complications (fig. 7).  
 
 
 
Figure 7. The distribution of the answers about willingness-to-pay to avoid UTIs 
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Willingness to pay results to avoid every fourth UTI for men and women 
The willingness-to-pay to avoid every fourth UTI for the men was 93 SEK. It was higher for women, 
161 SEK (fig. 8).  
 
 
 
Figure 8. Willingness-to pay (WTP) to avoid every fourth UTI (SEK) for men and women 
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the male respondents the situation was the opposite. The men with UTIs≥2 were willing to spend 75 
SEK and those with few UTIs 97 SEK (fig. 9). 
 
 
 
Figure 9. Willingness-to pay to avoid UTIs (SEK) for men and women and stratified according to the annual number of UTIs 
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Willingness to pay results to avoid half of the UTIs for men and women 
The willingness-to-pay to avoid half of the UTIs for the men was 143 SEK, which was 54% more than 
the WTP to avoid every fourth UTI. It was higher for women, 224 SEK, which was 39% more than to 
avoid every fourth UTI (fig. 10).  
 
 
 
Figure 10. Willingness-to pay (WTP) to avoid half of the UTIs (SEK) for men and women 
 
 
 
When the female respondents were divided into groups dependent on the number of annual UTIs, 
the women with UTIs≥2 were willing to spend more than five times as much as the women with few 
UTIs. The willingness-to-pay to avoid half of the UTIs was 470 SEK versus 83 SEK, respectively. Also 
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the male respondents with more UTIs were willing to spend more money on the prevention, 175 SEK 
versus 135 SEK (fig. 11). 
 
 
 
Figure 11. Willingness-to pay to avoid UTIs (SEK) for men and women and stratified according to the annual number of UTIs 
 
 
 
  
95%
N Mean Conf. (±) Std.Error Std.Dev.
Female UTI≤1 18 83 77 36 154
Male UTI≤1 34 135 88 43 252
Female UTI≥2 10 470 268 118 374
Male UTI≥2 8 175 177 75 212
83
135
470
175
FEMALE UTI≤1 MALE UTI≤1 FEMALE UTI≥2 MALE UTI≥2
M
ea
n
 
95% Confidence interval
24 
 
Analytical statistics 
 
Avoid every fourth UTI 
A Wilcoxon signed rank test was performed to test the null hypothesis of a probability of a 
willingness-to-pay to avoid every fourth UTI equal to 0 SEK at the p-level 0.05. The test confirmed the 
alternative hypothesis and showed there is a significant willingness-to-pay (p=0.000004) (fig. 12). 
 
Mann-Whitney’s tests to compare two independent samples were run to investigate if the significant 
willingness-to-pay to avoid every fourth UTI was dependent on sex and annual frequency of UTI. The 
results showed no difference between men and women (p=0.35), but having more than one UTI per 
year reached statistical significance (p=0.035) (fig. 12). 
 
Figure 12. Significance testing of the probability of WTP equal to 0 SEK to avoid every fourth UTI, no difference between 
men and women and no difference due to annual UTI frequency 
 
 
 
 
Additional analyses were performed to investigate if there were any differences between the 
following subgroups: (1) men and UTI≤1, (2) men and UTI≥2, (3) women and UTI≤1 and (4) women 
and UTI≥2. 
A Kruskal-Wallis one-way analysis of variance was chosen to compare many unpaired samples. It 
discovered a significant difference in the willingness-to-pay to avoid every fourth UTI between the 
U-Test (Mann-Whitney)
N Mean Rank U
Sex
Female 28 37,911 655,5
Wilcoxon test Male 42 33,893 520,5
HO Z P
0,935 0,350
Differences N Rank-Sum
Negative 26 351
Positive 0 0 U-Test (Mann-Whitney)
Zero 44
N Mean Rank U
Z P Annual 
-4,457 0,000004 One-sided UTI≤1 52 32,885 332
UTI≥2 18 43,056 604
Z P
2,111 0,035
There is no WTP to avoid every fourth UTI
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groups. Mann-Whitney’s tests followed and showed that the difference between women with more 
or less UTIs contributed most to the significant result (fig. 13). 
 
 
Figure 13. Significance testing of the probability of WTP equal to 0 SEK to avoid every fourth UTI between the subgroups (1) 
men and UTI≤1, (2) men and UTI≥2, (3) women and UTI≤1 and (4) women and UTI≥2 
 
 
  
U-Test (Mann-Whitney)
N Mean Rank U
Female UTI≤1 18 11,861 42,5
Female UTI≥2 10 19,25 137,5
Z P
2,531 0,011
U-Test (Mann-Whitney)
N Mean Rank U
Male UTI≤1 34 21,397 132,5
H-Test (Kruskal-Wallis) Male UTI≥2 8 21,938 139,5
N Mean Rank
Z P
Female UTI≤1 18 31,25 0,134 0,894
Male UTI≤1 34 33,75
Female UTI≥2 10 49,9
Male UTI≥2 8 34,5 U-Test (Mann-Whitney)
H Degrees of P N Mean Rank U
8,090 3 0,044
Female UTI≤1 18 25,306 284,5
Male UTI≤1 34 27,132 327,5
Z P
-0,507 0,612
U-Test (Mann-Whitney)
N Mean Rank U
Female UTI≥2 10 11,400 59
Male UTI≥2 8 7,125 21
Z P
-1,771 0,0766
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Avoid half of the UTIs 
A Wilcoxon signed rank test was performed to test the null hypothesis of a probability of a 
willingness-to-pay to avoid half of the UTIs equal to 0 SEK at the p-level 0.05. The test confirmed the 
alternative hypothesis and showed there is a significant willingness-to-pay (p=0.0000003) (fig. 14). 
 
Mann-Whitney’s tests to compare two independent samples were run to investigate if the significant 
willingness-to-pay to avoid half of the UTIs was dependent on sex or annual frequency of UTIs. The 
results showed no difference between men and women (p=0.35), but having more than one UTI/year 
reached statistical significance (p=0.003) (fig. 14). 
 
 
 
Figure 14. Significance testing of the probability of WTP equal to 0 SEK to avoid half of the UTIs, no difference between men 
and women and no difference due to annual UTI frequency 
 
 
 
Additional analyses were performed to investigate if there were any differences between the 
following subgroups: (1) men and UTI≤1, (2) men and UTI≥2, (3) women and UTI≤1 and (4) women 
and UTI≥2. 
 
A Kruskal-Wallis one-way analysis of variance was chosen to compare many unpaired samples. It 
discovered a significant difference in the willingness-to-pay to avoid half of the UTIs between the 
groups. Mann-Whitney’s tests followed and showed that the difference between women with more 
or less UTIs contributed most to the significant result (fig. 15). 
 
U-Test (Mann-Whitney)
N Mean Rank U
Sex
Wilcoxon test Female 28 38,375 668,5
Male 42 33,583 507,5
H0:
Z P
Differences N Rank-Sum 1,049 0,294
Negative 33 561
Positive 0 0
Zero 37 U-Test (Mann-Whitney)
Z P N Mean Rank U
-5,012 0,0000003 One-sided Annual 
UTI≤1 52 31,654 268
UTI≥2 18 46,611 668
Z P
2,921 0,003
There is no WTP to avoid half of the UTIs
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Figure 15. Significance testing of the probability of WTP equal to 0 SEK to avoid half of the UTIs between the subgroups (1) 
men and UTI≤1, (2) men and UTI≥2, (3) women and UTI≤1 and (4) women and UTI≥2 
 
 
 
  
U-Test (Mann-Whitney)
N Mean Rank U
Female UTI≤1 18 11,389 34
Female UTI≥2 10 20,100 146
Z P
2,840 0,005
U-Test (Mann-Whitney)
N Mean Rank U
H-Test (Kruskal-Wallis) Male UTI≤1 34 20,588 105
Male UTI≥2 8 25,375 167
N Mean Rank Z P
1,104 0,269
Female UTI≤1 18 30,694
Male UTI≤1 34 32,162
Female UTI≥2 10 52,2 U-Test (Mann-Whitney)
Male UTI≥2 8 39,625
H Degrees of P N Mean Rank U
10,606 3 0,014
Female UTI≤1 18 25,972 296,5
Male UTI≤1 34 26,779 315,5
Z P
-0,209 0,834
U-Test (Mann-Whitney)
N Mean Rank U
Female UTI≥2 10 11,400 59
Male UTI≥2 8 7,125 21
Z P
-1,713 0,087
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Conclusion 
This study confirms that urinary tract infection is a common complication among users of 
intermittent urinary catheters, but the annual frequency of UTIs of 1.23 was only half as many as 
reported by Woodbury et al. (2008) where the annual frequency was 2.6. Both studies show that the 
UTI incidence is higher among women. 
 
Approximately every fourth respondent in the study population reported they have two or more UTIs 
per year. The share of patients with two or more UTIs is smaller than reported in the study by 
Biering-Sorensen et al. (1999) were approximately every third patient had 2 or more infections per 
year.  
 
An explanation to the difference discovered in this survey, can be the development of urinary 
catheters that has occurred the last decade. Nevertheless, since UTI is still a frequent problem 
associated with intermittent catheterization, there is a need to develop more effective catheters or 
find other solutions to reduce the frequency of this complication. 
 
The request for better catheters was reflected in the survey respondents’ willingness-to-pay for a 
switch from the existing catheter to a hypothetically more effective one of the same quality. As 
expected, the wish for a better catheter was dependent on the frequency of urinary tract infections. 
The respondents’ readiness to spend money to get a more effective catheter reveals their concern 
about urinary tract infections.  
 
Surprisingly, there was a large share of respondents who were not willing to spend any money at all. 
A possible explanation can be that the users normally get their catheters for free in a healthcare 
system financed by taxes as in Sweden. The contribution of out-of-pocket payment is not an issue to 
consider and difficult to even imagine. 
 
The overall willingness-to-pay results were higher for the women than for the men, both to avoid 
every fourth and every second UTI (161 versus 93 SEK and 224 versus 143 SEK, respectively). This 
gender difference is difficult to explain. Perhaps there is a difference in the UTI severity between 
women and men and hence, in the subjective experience of this complication associated with 
intermittent catheterization. It needs to be investigated further.  
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There was an expected difference in the willingness-to-pay for more effective catheters depending 
on the annual frequency of UTIs and the patients with one UTI or less versus those with more than 
one UTI per year. Also here, the difference was larger among the women which further emphasize 
the need to understand if women with many infections have a stronger need for solutions to reduce 
the frequency of UTIs. 
 
This study wanted to investigate if there is willingness-to-pay (WTP) - from a patient perspective - for 
a urinary catheter which reduces the annual frequency of urinary tract infection by 25% and 50%, 
respectively. In both situations there were a significant WTP and the null hypothesis was rejected.  The 
statistical testing showed that in both situations the difference between women with more or less UTIs 
contributed most to the significant results.  
 
Reduction in the frequency of catheter-associated UTIs will benefit the users of intermittent urinary 
catheters by improving their quality of life. It will also benefit the health care organization and payers 
of health care when lesser resources are spent on treating the infections and other complications. A 
focus on solutions to treat the patients with the most frequent problems appears to be most 
valuable. 
 
Example: The value of a more effective urinary catheter in the group with UTI ≥2 
The cost utility analysis of intermittent urinary catheters by Bermingham et al. (BMJ, 2013), uses 
assumptions regarding costs and complications to UTIs23. If the same transition probabilities to have 
a 1st line antibiotic resistant UTI, multidrug resistant UTI or to develop bacteremia are applied to the 
results, a simplified cost-of-illness calculation which only focuses on UTIs can be performed. In the 
study, 8.3% of the users with UTI≥2 are resistant to the first line antibiotic treatment, 7% of them 
have a multidrug resistant UTI, 3.6% develop bacteremia. The costs are 738 SEK, 23.428 SEK and 
34.610 SEK, respectively. A non-complicated symptomatic UTI costs 531 SEK.24 
 
The group of men and women with more than one UTI per year (n=18) causes the following costs 
related to urinary tract infections when the input from Bermingham et al. is used: 
                                                          
23Bermingham, BMJ, 2013 
24 Pound conversion to SEK, www.valuta.se, 2014-04-07  
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 Symptomatic UTI: (18-1,5-1,3-0,6)  x 531 SEK 
 1st line antibiotic resistant UTI: n=1,5 x 739 SEK (n is rounded up)  
 Multidrug resistant UTI: n=1,3 x 23.428 SEK (n is rounded up)  
 Bacteremia: n=0,6 x 34.610 SEK (n is rounded down)  
 
This equals a cost of approximately 60.000 SEK per year or 3300 SEK per patient.  
 
As previously mentioned, urinary tract infections and complications are also associated with lower 
quality of life. In the WTP analysis, which focused on the prevention of UTIs with better catheters, 
the possible quality-of-life gains were not measured. In an electronic survey with a recall period of 
one year, it is also difficult to accurately share information of the quality of life decrements at the 
time of the infection or infections. As a proxy variable, the patients’ preference for a more efficacious 
catheter was measured by the patient responses on how much they were willing to pay per month 
using explicit amounts from 0 SEK to 1000 SEK in 100 SEK increments. The monthly willingness-to-pay 
to avoid every fourth UTI was 222 SEK25 and to avoid half of the UTIs 339 SEK26 in the group with 
more than one UTI per year. The WTP for a year is: 
 
 222 SEK x 12 months = 2664 SEK for every fourth UTI avoided 
 339 SEK x 12 months = 4068 SEK for every second UTI avoided 
 
If the value of a new hypothetical catheter, or catheter plus support package, is a combination of the 
(1) value experienced by the patient and (2) the savings for the health care system for avoiding 
infections, then the total value per patient with more than one infection per year is:   
 
 825* + 2664 = 3489 SEK to avoid every fourth UTI (*3300 SEK/4 =825 SEK)  
 1650** + 4068 = 5718 SEK to avoid half of the UTIs (**3300 SEK/2 = 1650 SEK)  
 
In summary, this survey study suggests that any new intermittent catheter with or without another 
solution such as educational support, which reduce the UTI frequency by 25%, can cost 3500 SEK 
more per year than the current alternative to be cost neutral to the Swedish health care system 
when also the value experienced by the patient is included in the evaluation. If the UTI frequency is 
reduced by 50%, it can cost 5700 SEK more per year.  
                                                          
25 ((n=10 x 340 SEK) +(n=8 x 75))/18 
26 ((n=10 x 470 SEK) +(n=8 x 175))/18 
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Attachment 1 - Questionnaire  
 
 
Initial input data 
 
Sex       
 
 
 
[  ]  male             [  ] female 
             
  
Estimate the number of catheters you 
normally use per day:  
 
_______________________ 
 
Estimate the number of urinary tract 
infections you normally have per year: 
 
 
_______________________ 
  
  
Catheter brand/type you use today:  _______________________ 
 
 
 
Introduction: 
The purpose of this study is to try to capture the value of a hypothetical catheter type, which 
presumably reduces the frequency of urinary tract infections including possible complications of such 
an event.  Either every fourth urinary tract infection is avoided (situation 1) or half of the urinary 
tract infections are avoided (situation 2).  We ask you to imagine - for this study only - a situation 
where you would have to pay for this new catheter type yourself, even though this would not be the 
situation in real life. 
 
 
 
Description of catheter types: 
In the table below, two different catheters are described. Assume that you are using catheter A. You 
have the choice to switch to catheter B. A very similar catheter, but this one reduces the frequency of 
urinary tract infections including possible complications. 
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Situation 1: 
 Catheter A Catheter B 
Reduction of urinary 
tract infections 
including possible 
complications: 
Same frequency of urinary tract 
infections including possible 
complications per year as with the 
catheter you currently use 
Every fourth urinary tract infection 
including possible complications 
which you experience with your 
current catheter will be avoided 
 
1. How much are you willing to pay each month for catheter B, if this catheter can help you 
avoid every fourth urinary tract infection including possible complications? (Check one box 
only)  
[  ] SEK 0 
[  ] SEK 100 
[  ] SEK 200 
[  ] SEK 300 
[  ] SEK 400 
[  ] SEK 500 
 
 
[  ] SEK 600 
[  ] SEK 700 
[  ] SEK 800 
[  ] SEK 900 
[  ] SEK 1000 
[  ] Other amount: _____
================================================================================== 
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Situation 2: 
 Catheter A Catheter B 
Reduction of urinary 
tract infections 
including possible 
complications: 
Same frequency of urinary tract 
infections including possible 
complications per year as with the 
catheter you currently use 
You will avoid half of the urinary 
tract infections including possible 
complications which you experience 
with your current catheter 
 
2. How much are you willing to pay each month for catheter B, if this catheter can help you 
avoid half of your urinary tract infections including possible complications? (Check one box 
only) 
[  ] SEK 0 
[  ] SEK 100 
[  ] SEK 200 
[  ] SEK 300 
[  ] SEK 400 
[  ] SEK 500 
[  ] SEK 600 
[  ] SEK 700 
[  ] SEK 800 
[  ] SEK 900 
[  ] SEK 1000 
[  ] Other amount: ______ 
 
================================================================================== 
 
 
 
3. How certain are you regarding your answers? (check one box only) 
 
 
 
 
Very uncertain 
 
Uncertain 
 
 
 
 
Certain 
 
Very certain 
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Attachment 2 – Patient database (TellUS) 
 
 
 
 
Wellspect HealthCare had at the time of the study more than 1000 European and US catheter users 
registered in the TellUS database. The database is used to perform various surveys, for instance in 
the fields of marketing and health economics. Background data is presented below to describe the 
patient cohort and to illustrate how representative it is for the patients using intermittent urinary 
catheters on a daily basis.  
 
In the study only the patients from Sweden were included.  Please note that some individuals have 
not entered all background data and the data set contains missing values. Hence, the patient 
numbers in the graphs vary depending on the parameters. The parameters included here are:  
 
(1) sex 
(2) age  
(3) years of CIC 
(4) numbers of catheters per day 
(5) diagnosis 
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(1) Men/Women 
 
 
 
 
 
 
 
men women
611 ( 61%)
393 ( 39%)
10
146 142
59
7
116 113
1811
139
44
40
11
54 84
10
women
men
48% 51%
76%
60%
39%
68%
57% 64%
52% 49%
24%
40%
61%
32%
43% 36%
men women
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(2) Age 
 
 
 
 
 
 
 
 
 
 
 
 
  
58 
y
49 
y
men women
mean age
0
49 y 48 y
60 y
46 y
61 y 60 y 59 y
mean age
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(3) Years of CIC 
 
 
 
 
 
 
 
 
 
 
 
  
13 y
12 y 11 y
15 y
13 y
12 y 12 y
9 y
12 y
mean time with CIC
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(4) Catheters per day 
 
 
 
 
 
 
 
 
 
 
 
  
4,0 4,2
men women
catheters/da
y
4,0
4,3
4,2
3,9
4,1
4,0 4,0
4,1
4,1
catheters /day 
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(5) Diagnosis 
 
 
BPH 3,9% 
MS 11,9% 
PD 0,3% 
SB 9,0% 
SCI para 23,2% 
SCI tetra 4,5% 
cancer 2,7% 
diabetes 0,7% 
other 40,4% 
post op 3,5% 
 
 
 
 
 
 
 
3,9%
11,9%
0,3%
9,0%
23,2%
4,5%2,7%
0,7%
40,4%
3,5%
BPH
MS
PD
SB
SCI para
SCI tetra
cancer
diabetes
other
post op
